XHANCE (fluticasone proprionate)

SELF ADMINISTRATION - NASAL SPRAY

Indications for Prior Authorization:

  • The treatment of nasal polyps in patients 18 years of age or older.

Patients must meet the following criteria for the indication(s) above:

  • Patient is 18 years of age or older, AND
  • Chart note documentation required documenting diagnosis of nasal polyps, AND
  • Patient has tried and failed mometasone nasal spray.

Dosing:

  • Up to 2 sprays in each nostril twice daily (total daily dose 744 mcg).
    • One unit provides 120 metered sprays.

Approval:

  • 1 year

Last review date: March 25, 2021